Phio Pharmaceuticals Corp (PHIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2012 | 03-2012 | 12-2011 | 09-2011 | 06-2011 | |
| Operating Expenses | 7,663 | 1,905 | 2,510 | 2,167 | 2,838 |
| Operating Income | -7,663 | -1,905 | -2,510 | -2,167 | -2,838 |
| Other Income | 64 | -21 | 60 | 124 | 956 |
| Pre-tax Income | -7,599 | -1,926 | -2,450 | -2,043 | -1,882 |
| Net Income Continuous | -7,599 | -1,926 | -2,450 | -2,043 | -1,882 |
| Net Income | $-7,599 | $-1,926 | $-2,450 | $-2,043 | $-1,882 |
| EPS Basic Total Ops | -4.13 | -0.04 | 0.01 | -0.05 | -0.05 |
| EPS Basic Continuous Ops | -1.72 | -0.04 | 0.01 | -0.05 | -0.05 |
| EPS Diluted Total Ops | -4.13 | -0.04 | 0.01 | -0.05 | -0.05 |
| EPS Diluted Continuous Ops | -1.72 | -0.04 | 0.01 | -0.05 | -0.05 |
| EBITDA(a) | $-7,624 | $-1,865 | $-2,474 | $-2,126 | $-2,792 |